Vasopressin In 0.9% Sodium Chloride Solution
NDC Package 81298-8554-3
Package Information
Vasopressin In 0.9% Sodium Chloride (vasopressin) solution is vasopressin in Sodium Chloride Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. This formulation utilizes a solution delivery system. Marketed by Long Grove Pharmaceuticals, Llc, this product is identified by NDC 81298-8554 and is authorized under FDA application NDA217766.
Identification & Billing
- RxCUI: 2399907 - vasopressin (USP) 40 UNT in 100 ML Injection
- RxCUI: 2399907 - 100 ML vasopressin (USP) 0.4 UNT/ML Injection
- RxCUI: 2399907 - vasopressin (USP) 40 UNT per 100 ML Injection
- RxCUI: 2591428 - vasopressin (USP) 20 UNT in 100 ML Injection
- RxCUI: 2591428 - 100 ML vasopressin (USP) 0.2 UNT/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81298 - Long Grove Pharmaceuticals, Llc
- 81298-8554 - Vasopressin In 0.9% Sodium Chloride
- 81298-8554-3 - 10 VIAL, SINGLE-DOSE in 1 CARTON / 100 mL in 1 VIAL, SINGLE-DOSE (81298-8554-1)
- 81298-8554 - Vasopressin In 0.9% Sodium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81298-8554-3 identifies a specific commercial package of 10 vial, single-dose in 1 carton / 100 ml in 1 vial, single-dose (81298-8554-1) of Vasopressin In 0.9% Sodium Chloride, a human prescription drug labeled by Long Grove Pharmaceuticals, Llc. This solution is formulated for intravenous use and contains vasopressin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Long Grove Pharmaceuticals, Llc on July 12, 2024. The current certification is valid through December 31, 2026.
How is this Long Grove Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81298855403. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.